AI-generated summary
The authors report a randomized, double-masked, sham-controlled trial of intense pulsed light in 114 patients with meibomian gland dysfunction. At 6 months, the IPL group showed better tear breakup time, meibum quality, expressibility, and symptom scores than the sham group, and no adverse events were recorded after IPL.
- Participants
- 114
- Who or what was studied
- Patients with meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not report the wavelength used, and it reports only a single trial, so the certainty of the findings is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Sham, Adverse event, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.